Published: 8:29AM Friday November 16, 2007
Source: Newstalk ZB
A Christchurch neurologist is describing a new drug being trialled on multiple sclerosis sufferers as a dream.
Doctor Deborah Mason, a consultant at Christchurch Hospital, is running one of a number of safety trials around the world for the drug Tysabri - a monoclonal antibody for the treatment of MS.
She has four patients on the trial and says they have all tolerated it very well.
Mason says there is mounting evidence Tysabri has the potential to keep patients in the early stages of the disease from progressing.
Her patients have all so far remained at the mild end of the disease spectrum.
Multiple sclerosis us a chronic, unpredictable disease of the central nervous system for which there is no known cure.
Provocative, unflinching, Thursday 9:30pm
Back Benches - giving politics back to the people
The way New Zealand wakes up weekdays, 6:30am
No one gets you closer, weeknights 7pm
Looking out for the little guy, Wednesday 7:30pm
Meet the people that bring you the news
TV ONE weekdays, 6am
The home of NZ politics - Sunday, 9am TV ONE
Where there's a story, we'll find it, Sunday 7:30pm
Te Karere, Maori News - 4pm weekdays, TV ONE
News on digital channel TVNZ 7
Advertising
